Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q2T9Q2

Entry ID Method Resolution Chain Position Source
AF-Q2T9Q2-F1 Predicted AlphaFoldDB

79 variants for Q2T9Q2

Variant ID(s) Position Change Description Diseaes Association Provenance
rs468630725 17 V>G No EVA
rs207978260 46 R>H No EVA
rs446276119 54 K>N No EVA
rs466955082 57 S>P No EVA
rs446985806 58 D>H No EVA
rs461973780 59 Y>H No EVA
rs441831807 59 Y>S No EVA
rs483015090 60 R>H No EVA
rs439445649 61 I>M No EVA
rs470590499 63 P>A No EVA
rs470590499 63 P>T No EVA
rs453556424 64 N>T No EVA
rs440094955 65 A>P No EVA
rs474497208 66 S>A No EVA
rs474497208 66 S>P No EVA
rs455018545 67 I>T No EVA
rs438187864 68 S>G No EVA
rs469560238 68 S>R No EVA
rs432632861 69 V>G No EVA
rs452739230 69 V>L No EVA
rs466997009 70 V>F No EVA
rs446848863 70 V>G No EVA
rs467868633 71 V>A No EVA
rs467868633 71 V>G No EVA
rs482901362 72 R>G No EVA
rs462719038 72 R>P No EVA
rs460013033 74 L>R No EVA
rs477320728 74 L>V No EVA
rs439956067 75 E>K No EVA
rs444081545 76 K>N No EVA
rs460888455 76 K>R No EVA
rs460888455 76 K>T No EVA
rs378745620 77 P>L No EVA
rs378745620 77 P>R No EVA
rs476027820 77 P>T No EVA
rs453379304 80 E>G No EVA
rs467731271 81 D>A No EVA
rs436381657 81 D>Y No EVA
rs450912037 82 T>P No EVA
rs437262761 84 L>P No EVA
rs437262761 84 L>R No EVA
rs477153707 89 W>G No EVA
rs460276917 91 H>P No EVA
rs480835202 94 Q>P No EVA
rs460751870 96 L>Q No EVA
rs444119417 99 H>Q No EVA
rs475529631 100 F>S No EVA
rs459121709 101 G>W No EVA
rs473546877 112 L>R No EVA
rs435268248 113 R>M No EVA
rs474218128 115 E>D No EVA
rs436654225 115 E>G No EVA
rs453638813 115 E>K No EVA
rs876444985 116 H>P No EVA
rs876259749 117 E>G No EVA
rs457314394 118 E>G No EVA
rs437318449 119 C>G No EVA
rs876232078 119 C>W No EVA
rs451658961 124 S>R No EVA
rs432157321 127 D>A No EVA
rs466568505 127 D>E No EVA
rs432157321 127 D>G No EVA
rs446720589 128 L>P No EVA
rs481097556 130 Q>E No EVA
rs467375318 131 L>R No EVA
rs450453691 133 R>L No EVA
rs482022290 134 Y>D No EVA
rs458652275 134 Y>S No EVA
rs438477307 135 L>V No EVA
rs480027572 139 E>A No EVA
rs443173541 148 R>T No EVA
rs474483922 149 E>* No EVA
rs457313866 149 E>G No EVA
rs443613876 150 P>T No EVA
rs451793305 160 E>K No EVA
rs434819486 162 E>D No EVA
rs521870409 162 E>G No EVA
rs466631836 164 V>F No EVA
rs436292262 166 Q>K No EVA

No associated diseases with Q2T9Q2

6 regional properties for Q2T9Q2

Type Name Position InterPro Accession
domain Ubiquitin-like domain 1 - 73 IPR000626
conserved_site Ubiquitin conserved site 27 - 52 IPR019954
domain Ubiquitin domain 11 - 31 IPR019956-1
domain Ubiquitin domain 32 - 52 IPR019956-2
domain Ubiquitin domain 53 - 74 IPR019956-3
domain Ubl4, C-terminal TUGS domain 89 - 135 IPR041421

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

No GO annotations of biological process

Name Definition
No GO annotations for biological process

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P11441 UBL4A Ubiquitin-like protein 4A Homo sapiens (Human) PR
Q9Z2F2 Oasl2 2'-5'-oligoadenylate synthase-like protein 2 Mus musculus (Mouse) PR
P11928 Oas1a 2'-5'-oligoadenylate synthase 1A Mus musculus (Mouse) PR
Q9CQ84 Ubl4b Ubiquitin-like protein 4B Mus musculus (Mouse) PR
Q5MYT9 Oasl2 2'-5'-oligoadenylate synthase-like protein 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MFLTVKLLLG RRCSLKVSGQ ESVAMLKKLV SERLHVPEEQ QHLLFRGQLL ADDKRLSDYR
70 80 90 100 110 120
IGPNASISVV VRPLEKPAPE DTRLPQPLWH HLGQVLAKHF GPQDTEAMLQ LLRREHEECL
130 140 150 160
QRISLGDLEQ LARYLLTKEP LAQPTGEREP EVLSPNKEEE KEAVQ